Stryker Corp. logo

SYK

Stryker Corp.

$281.87
+2.29%
Last updated 10:32 PM
Stryker Corp logo

Stryker Corp

Stryker Corp is a Health Care company listed on NEW YORK STOCK EXCHANGE, INC..

Industry
Health Care
Exchange
NEW YORK STOCK EXCHANGE, INC.
Market Cap
$105.7B
P/E Ratio
28.3
Cash on Hand
$4.1B(positive)
Shares Outstanding
383.4M shares
Currency
USD
Visit website →

About

Stryker Corporation is an American multinational medical technologies corporation based in Portage, Michigan, United States. The company's products are used for medical surgery and neurotechnology, which include surgical equipment, patient and caregiver safety technologies, endoscopy systems, and patient handling, emergency medical equipment, and intensive care disposable products, as well as neurosurgical, neurovascular and oral and maxillofacial surgery implant products; and orthopedic surgery, which includes implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. Stryker's products are sold in over 75 countries and are used by 150 million patients annually. In 2024, 75% of the company's revenues came from the United States.

via Wikipedia →

Earnings (EPS)

QuarterEPS EstimateEPS Actual
Q2 2026$3.52$3.69
Q1 2026$3.01$2.60
Q4 2025$4.44$4.47
Q3 2025$3.16$3.19

Financial Highlights

The basics, explained simply — no finance degree required.

52-Week Range
$267.00 – $392.55

The lowest and highest price this stock has traded at over the past year.

Dividend Yield
1.02%

How much this stock pays you back each year, just for holding it — as a % of the share price.

Profit Margin
14.4%

How much of every $1 in sales turns into actual profit. Higher generally means a healthier business.

Revenue Growth
+8.5%

How much the company's sales grew compared to a year ago.

Volatility (Beta)
0.80

How much this stock tends to swing compared to the overall market. Above 1 means it typically moves more than the market (higher risk, higher potential reward); below 1 means it's historically calmer.

Analyst Insights

Analyst Consensus
Buy

Based on 34 analysts

Next Earnings
Oct 28, 2026
Similar Companies

Insider Activity

Recent buys and sells by company executives and directors — publicly disclosed, as required by law.

Crotty Dylan Bram
Aug 21, 2026 • $328.61/share
Sold 441
Fink M Kathryn
Aug 1, 2026 • $325.70/share
Sold 111
Fletcher Robert S
Aug 1, 2026 • $325.70/share
Sold 94
King Debra
Aug 1, 2026 • $325.70/share
Sold 533
Montagnino Kimberly Ann
Aug 1, 2026 • $325.70/share
Sold 155
Stiles Spencer S
Jun 1, 2026
Sold 1,607

Recent News